Detalhe da pesquisa
1.
Relationship of nursing education and care management inpatient rehabilitation interventions and patient characteristics to outcomes following spinal cord injury: the SCIRehab project.
J Spinal Cord Med
; 35(6): 593-610, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23318039
2.
The SCIRehab project: treatment time spent in SCI rehabilitation. Nursing bedside education and care management time during inpatient spinal cord injury rehabilitation.
J Spinal Cord Med
; 34(2): 205-15, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21675359
3.
Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.
J Clin Endocrinol Metab
; 94(1): 246-54, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18984660
4.
Regulation of basal, pulsatile, and entropic (patterned) modes of GH secretion in a putatively low-somatostatin milieu in women.
Am J Physiol Endocrinol Metab
; 297(2): E483-9, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19491298
5.
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.
Am J Physiol Endocrinol Metab
; 297(2): E367-74, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19470834
6.
SCIRehab Project series: the supplemental nursing taxonomy.
J Spinal Cord Med
; 32(3): 329-35, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19810634
7.
Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women.
J Clin Endocrinol Metab
; 93(3): 951-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18089703
8.
Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.
J Clin Endocrinol Metab
; 93(3): 944-50, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18073313
9.
Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.
J Clin Endocrinol Metab
; 93(11): 4471-8, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18728158
10.
A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans.
J Clin Endocrinol Metab
; 95(8): 3844-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20444908
11.
Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
J Clin Endocrinol Metab
; 95(1): 353-60, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19858315
12.
Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
J Clin Endocrinol Metab
; 94(6): 2137-43, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19351723
13.
Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
Eur J Endocrinol
; 161(2): 293-300, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19458139
14.
Testosterone's short-term positive effect on luteinizing-hormone secretory-burst mass and its negative effect on secretory-burst frequency are attenuated in middle-aged men.
J Clin Endocrinol Metab
; 94(10): 3978-86, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19584190